News:
ePaper |
Front Page |
National |
Tamil Nadu |
Andhra Pradesh |
Karnataka |
Kerala |
New Delhi |
Other States |
International |
Opinion |
Business |
Sport |
Miscellaneous |
Engagements |
Advts:
Retail Plus |
Classifieds |
Jobs |
Obituary |
Andhra Pradesh
-
Hyderabad
Clinical trials of H1N1 vaccine begin
HYDERABAD: Bharat Biotech on Tuesday announced commencement of the phase one clinical evaluation of HN-VAC , its cell culture-based H1N1 vaccine. It received the nod from the Drugs Controller-General of India (DCGI) to conduct the trials.
The company said in a press release that the vaccine under development would boost immunity against the new H1N1 influenza strains and help protect public health as the pandemic evolves. It is the first company in the country to develop, a cell culture-based vaccine for influenza, which can serve as a platform technology for both pandemic and seasonal flu vaccines.
The company has received the H1N1 vaccine strains from WHO/CDC centres.
Printer friendly
page
Send this article to Friends by
E-Mail
Andhra Pradesh
News:
ePaper |
Front Page |
National |
Tamil Nadu |
Andhra Pradesh |
Karnataka |
Kerala |
New Delhi |
Other States |
International |
Opinion |
Business |
Sport |
Miscellaneous |
Engagements |
Advts:
Retail Plus |
Classifieds |
Jobs |
Obituary |
Updates:
Breaking News |
|
